Literature DB >> 28666315

Lack of growth inhibitory synergism with combined MAPK/PI3K inhibition in preclinical models of pancreatic cancer.

L Ciuffreda1, A Del Curatolo2, I Falcone3, F Conciatori4, C Bazzichetto4, F Cognetti3, V Corbo2, A Scarpa2, M Milella1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28666315     DOI： 10.1093/annonc/mdx335

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  6 in total

Review 1.  mTOR Cross-Talk in Cancer and Potential for Combination Therapy.

Authors:  Fabiana Conciatori; Ludovica Ciuffreda; Chiara Bazzichetto; Italia Falcone; Sara Pilotto; Emilio Bria; Francesco Cognetti; Michele Milella
Journal:  Cancers (Basel)       Date:  2018-01-19       Impact factor: 6.639

Review 2.  Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches.

Authors:  Michael Orth; Philipp Metzger; Sabine Gerum; Julia Mayerle; Günter Schneider; Claus Belka; Maximilian Schnurr; Kirsten Lauber
Journal:  Radiat Oncol       Date:  2019-08-08       Impact factor: 3.481

Review 3.  From Genetic Alterations to Tumor Microenvironment: The Ariadne's String in Pancreatic Cancer.

Authors:  Chiara Bazzichetto; Fabiana Conciatori; Claudio Luchini; Francesca Simionato; Raffaela Santoro; Vanja Vaccaro; Vincenzo Corbo; Italia Falcone; Gianluigi Ferretti; Francesco Cognetti; Davide Melisi; Aldo Scarpa; Ludovica Ciuffreda; Michele Milella
Journal:  Cells       Date:  2020-01-28       Impact factor: 6.600

4.  Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes.

Authors:  Musalula Sinkala; Nicola Mulder; Darren Patrick Martin
Journal:  Oncotarget       Date:  2018-06-26

5.  NGF from pancreatic stellate cells induces pancreatic cancer proliferation and invasion by PI3K/AKT/GSK signal pathway.

Authors:  Jie Jiang; Jun Bai; Tao Qin; Zheng Wang; Liang Han
Journal:  J Cell Mol Med       Date:  2020-04-15       Impact factor: 5.310

Review 6.  KRAS wild-type pancreatic ductal adenocarcinoma: molecular pathology and therapeutic opportunities.

Authors:  Claudio Luchini; Gaetano Paolino; Paola Mattiolo; Maria L Piredda; Alessandro Cavaliere; Marina Gaule; Davide Melisi; Roberto Salvia; Giuseppe Malleo; Jae Il Shin; Sarah Cargnin; Salvatore Terrazzino; Rita T Lawlor; Michele Milella; Aldo Scarpa
Journal:  J Exp Clin Cancer Res       Date:  2020-10-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.